Skip to main content
SpringerLink
Log in

Antiplatelet Drug Management

  • Chapter
  • First Online:
Patient Blood Management in Cardiac Surgery

Abstract

The majority of patients undergoing cardiac surgery use antiplatelet agents, such as aspirin, ADP receptor inhibitors, and/or glycoprotein IIb/IIIa receptor inhibitors. An increasing number of patients use dual antiplatelet therapy. Due to the higher bleeding risk in the presence of antiplatelet agents, every individual patient requires a balanced estimation of the bleeding risks in case of continuation and thrombotic risks in case of cessation. This chapter describes different antiplatelet drugs, and the aspects that have to be considered for continuation or discontinuation of these agents before cardiac surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Oprea AD, Popescu WM. Perioperative management of antiplatelet therapy. Br J Anaesth. 2013;111:i3–i17.

    Article  Google Scholar 

  2. Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med. 2007;357:2482–94.

    Article  Google Scholar 

  3. Kubica J, Kozinski M, Navarese EP, et al. Cangrelor: an emerging therapeutic option for patients with coronary artery disease. Curr Med Res Opin. 2014;30:813–28.

    Article  CAS  Google Scholar 

  4. Koenig-Oberhuber V, Filipovic M. New antiplatelet drugs and new oral anticoagulants. Br J Anaesth. 2016;117:ii74–84.

    Article  CAS  Google Scholar 

  5. Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849–60.

    Article  Google Scholar 

  6. O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61:485–510.

    Article  Google Scholar 

  7. Mangano DT, Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med. 2002;347:1309–17.

    Article  CAS  Google Scholar 

  8. Goldman S, Copeland J, Moritz T, et al. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. Circulation. 1988;77:1324–32.

    Article  CAS  Google Scholar 

  9. Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2016;152:1243–75.

    Article  Google Scholar 

  10. Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e326–50.

    Article  Google Scholar 

  11. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. Eur Heart J. 2010;31:2501–55.

    Article  Google Scholar 

  12. Boer C, Meesters MI, Milojevic M, et al. 2017 EACTS/EACTA guidelines on patient blood management for adult cardiac surgery. J Cardiothorac Vasc Anesth. 2017;25:1–34.

    Google Scholar 

  13. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK, Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494–502.

    Article  CAS  Google Scholar 

  14. Sabatine MS, Jang IK. The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease. Am J Med. 2000;109:224–37.

    Article  CAS  Google Scholar 

  15. Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Anesth Analg. 2012;114:11–72.

    Article  Google Scholar 

  16. Bhatt DL, Stone GW, Mahaffey KW, et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med. 2013;368:1303–13.

    Article  CAS  Google Scholar 

  17. Campbell CL, Smyth S, Montalescot G, Steinhubl SR. Aspirin dose for the prevention of cardiovascular disease: a systematic review. J Am Med Assoc. 2007;297:2018–24.

    Article  CAS  Google Scholar 

  18. McQuaid KR, Laine L. Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med. 2006;119:624–38.

    Article  CAS  Google Scholar 

  19. He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. J Am Med Assoc. 1998;280:1930–5.

    Article  CAS  Google Scholar 

  20. Mantz J, Samama CM, Tubach F, et al. Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial. Br J Anaesth. 2011;107:899–910.

    Article  CAS  Google Scholar 

  21. Alghamdi AA, Moussa F, Fremes SE. Does the use of preoperative aspirin increase the risk of bleeding in patients undergoing coronary artery bypass grafting surgery? Systematic review and meta-analysis. J Card Surg. 2007;22:247–56.

    Article  Google Scholar 

  22. Pickard AS, Becker RC, Schumock GT, Frye CB. Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting. Pharmacotherapy. 2008;28:376–92.

    Article  CAS  Google Scholar 

  23. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045–57.

    Article  CAS  Google Scholar 

  24. Hansson EC, Jidéus L, Åberg B, et al. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study. Eur Heart J. 2016;37:189–97.

    Article  Google Scholar 

  25. PURSUIT Trial Investigators. Platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy. N Engl J Med. 1998;339:436–43.

    Article  Google Scholar 

  26. Memon MA, Blankenship JC, Wood GC, Frey CM, Menapace FJ. Incidence of intracranial hemorrhage complicating treatment with glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis of major clinical trials. Am J Med. 2000;109:213–7.

    Article  CAS  Google Scholar 

  27. Stawiarski K, Kataria R, Bravo CA, et al. Dual-antiplatelet therapy guidelines and implications for perioperative management. J Cardiothorac Vasc Anesth. 2018;32:1072–80.

    Article  Google Scholar 

  28. Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016. Eur J Anaesthesiol. 2017;34:332–95.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesia and Critical Care, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK

    Aamer Ahmed & Adeel Majeed

Authors
  1. Aamer Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adeel Majeed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aamer Ahmed .

Editor information

Editors and Affiliations

  1. Vivantes Klinikum im Friedrichshain, Berlin, Germany

    Christian von Heymann

  2. Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands

    Christa Boer

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ahmed, A., Majeed, A. (2019). Antiplatelet Drug Management. In: von Heymann, C., Boer, C. (eds) Patient Blood Management in Cardiac Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-15342-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-15342-7_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-15341-0

  • Online ISBN: 978-3-030-15342-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation